DEA temporarily extends COVID-19 telehealth prescribing flexibility for controlled substances
Health Care Dive
MAY 4, 2023
The agency said on Wednesday that it needs additional time to parse through the 38,000 public comments it received in response to a proposal to reintroduce stricter limits around telehealth prescribing.
Let's personalize your content